Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 195% for ...

On December 9, Barclays analyst Glen Santangelo initiated coverage of Viatris Inc. (NASDAQ:VTRS) with an Overweight rating ...

Novo Nordisk stated only that it was reducing the prices of its highly popular drug in China, although it did not provide ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the ridiculously cheap stocks to buy now. As of December 26, BioMarin ...

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income ...

Vertex Pharmaceuticals (VRTX) is a top biotech pick, with strong earnings, diverse pipelines, and growth prospects. See here ...

See why TG Therapeutics, Inc. earns a Buy rating, with insights on Briumvi's efficacy and market growth in multiple sclerosis ...

Equities were a touch weaker on the final trading day of 2025, trimming some of the gains that have powered global stocks to ...

Stocks wavered as traders awaited the release of minutes from the Federal Reserve’s December meeting for hints about the ...

Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to ...

Investing is one of the few businesses where you can do everything right and still lose money in the short term. What matters ...

Base salaries represent just a fraction of what these execs actually take home through stock awards, incentive plans, and ...